Heparin - B Braun issue nationwide product recall after supplier notifies contaminated suuples

B. Braun Medical Inc. (est.1839) began recalling 23 lots of pre- mixed injectable Heparin Sodium in 5% Dextrose and 0.9% Sodium Chloride injection solution on March 21st , 2008 from the US and Canada. This is a precautionary measure as their supplier, Scientific Protein Laboratories (SPL), disclosed that one lot of Heparin Sodium, USP Active Pharmaceutical Ingredient acquired by B. Braun Medical Inc. had a heparin-like contaminant.

To date, B. Braun Medical Inc. has not received any adverse event reports related to this issue. B Braun recall FDA recall notice